2025. June 12., Thursday
Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar

University of Szeged
Albert Szent-Györgyi Medical School
 
Foreign Students' Secretariat




Your Education. Our Mission.

0_invaziv_ize_1900x1068

World-class limb salvage surgery at the University of Szeged

Doctors at the Albert Szent-Györgyi Clinical Centre, University of Szeged performed a percutaneous vascular surgical intervention called orbital atherectomy to save a patient’s limb. Orbital atherectomy is the most up-to-date technique at present, and it is considered to be a novelty worldwide.

The device was originally developed to treat calcification of the coronary arteries, but it has already been used in the treatment of peripheral vascular disorders. In Central Europe the first such application was performed by the invasive cardiology team at the Albert Szent-Györgyi Clinical Centre. The successful intervention was performed by Dr. Habil. Zoltán Ruzsa, associate professor and Dr. Zoltán Jambrik, assistant professor.


1_fb_img_1666097597283_450x330


The circulation in the 66-year-old man's left leg was severely compromised due to chronic blockage of the artery supplying it, which could lead to gangrene or amputation. To save the limb, catheter-based intracvascular angioplasty was necessary to improve circulation. However, the severe calcification of the artery did not allow for balloon dilatation and stenting, which are now considered traditional, as effective treatment requires the removal of the calcific mass causing the stenosis first. The orbital atherectomy system uses a rotating drill that can be used to break down the sclerotic lesion. Its diamond-coated eccentric crown uses abrasion to grind away calcium crystals deposited in the vessel wall. This way the deposit will break up into tiny micro-particles that are simply washed out of the vessel by the bloodstream.


2_fb_img_1666097575657_450x330


Just like coronary artery disease, which causes serious heart problems, peripheral artery disease is becoming increasingly common. The increasing incidence of hypertension, diabetes, sedentary lifestyle and smoking are major predisposing factors to its development, which poses a significant challenge to cardiovascular specialists.


3_fb_img_1666097590080_330x330


At the Albert Szent-Györgyi Clinical Centre, the treatment of cardiovascular diseases including peripheral vascular disorders is carried out through interdisciplinary cooperation using the most modern technology. The introduction of state-of-the-art techniques and their application in daily practice (sometimes in a pioneering way to ensure effectiveness) is expected to open up new perspectives.

Latest news

SZTE-MSD_egyuttmukodesi_megallapodas_alairas_2

The University of Szeged and MSD have established a joint Pharmaceutical Industry Partnership Department, marking a new chapter in their collaboration. This initiative builds on a long-standing partnership – further strengthened in 2023 through clinical trial cooperation – and seeks to foster innovation in research, education, and pharmaceutical development. The agreement was officially signed in Szeged by Prof. Dr. László Rovó, Rector of the University of Szeged; Prof. Dr. Ildikó Csóka, Director-General for Strategic Planning; Prof. Dr. Zsolt Szakonyi, Dean of the Faculty of Pharmacy; Sean R. Smith, Managing Director of MSD Pharma Hungary Kft.; and Dr. Szabolcs Barótfi, Director of Clinical Research at MSD Hungary.

083a6605

On May 12, the University of Szeged held an official ceremony to inaugurate its new research unit: the Host–Pathogen Interaction Center. Located within the Institute of Biology, the Center features Hungary’s only in vivo experimental station of its kind, alongside five newly renovated laboratories. This state-of-the-art facility is designed to support the development of antimicrobial therapies, with a particular focus on antifungal treatments – addressing a pressing yet often overlooked public health concern. The project was made possible through both professional and financial support from Katalin Karikó, an SZTE alumna and recipient of the 2023 Nobel Prize in Physiology or Medicine.

KJA-Number-0879

The origins of the University of Szeged date back to May 12, 1581, when István Báthory established the Jesuit College in Cluj-Napoca – an institution recognized as SZTE's legal predecessor. Exactly 444 years later, the University marked this anniversary with a symbolic “birthday gift”: the signing of two strategic partnership agreements. Supported by two of South America’s leading scientific and healthcare institutions, these partnerships are set to position SZTE among the global research elite in emerging and internationally significant fields of healthcare research and education.